Business Context and Reporting Period
Aterian, Inc., identified in the filing as Mohawk Group Holdings, Inc., filed a Form 8-K dated February 8, 2021, with the report signed February 9, 2021. The filing reports material financing, warrant, note-amendment, securities-issuance, and voting-agreement transactions.
Key Financial and Capitalization Information
- High Trail Investments SA LLC exercised warrants for 980,000 common shares for aggregate proceeds of $8.83 million.
- High Trail also paid $16.96 million in exchange for cancellation of the unexercised portion of a prior warrant covering 1,884,133 shares.
- The company issued a penny warrant covering 1,884,133 shares, exercisable at $0.01 per share, and an additional warrant covering 750,000 shares, exercisable at $33.56 per share.
- The penny warrant is immediately exercisable, has a five-year term, and may be exercised on a cashless basis. The additional warrant is immediately exercisable, subject to stockholder approval for share issuance, and generally has a term extending to the later of five years from issuance or one year after required approvals.
- The filing does not provide revenue, net income, operating cash flow, margins, cash balances, liquidity ratios, or debt balances beyond references to senior secured notes due 2022 and 2023.
Material Changes Versus the Prior Comparable Period
- The December 2020 warrant covering up to 2,864,133 shares was amended to permit immediate cash exercise.
- The unexercised portion of that warrant was canceled in exchange for cash consideration and issuance of the penny warrant.
- The company issued an additional warrant and amended the 2022 note, 2023 note, and February warrant to limit share issuance or exercise pending Nasdaq-related stockholder approval.
- The beneficial ownership limitation for the February warrant increased from 4.99% to 9.99%; the penny and additional warrants also contain a 9.99% beneficial ownership limitation.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The company agreed to seek stockholder approval by a meeting to be held no later than May 31, 2021, to authorize share issuances exceeding Nasdaq Listing Rules 5635(a) and/or 5635(d) limitations.
- The additional warrant cannot be exercised for shares requiring the specified stockholder approval unless that approval is obtained.
- Executive officers and directors entered into voting agreements supporting the required approvals. The company agreed to use best efforts to keep at least 850,000 shares subject to those agreements until approval or termination.
- The company agreed to file a resale registration statement by March 26, 2021 for the shares issued under the December warrant and shares issuable under the penny warrant.
- For the first 30 days after registration effectiveness, the investor agreed not to sell more than 10% of the common stock’s daily trading volume in the registered shares.
- The securities were issued in private transactions relying on Securities Act Section 4(a)(2) and Rule 506(b) of Regulation D. Resale is restricted absent registration or an applicable exemption.
- The transactions may create substantial potential dilution, although exercise is subject to ownership limitations and, for certain securities, stockholder approval.
Investor Verification Items
- Verify the final terms and exhibits for the penny warrant, additional warrant, note amendments, February warrant amendment, and voting agreements.
- Confirm whether the required stockholder approvals were obtained and the resulting maximum number of issuable shares.
- Review subsequent filings for effectiveness of the resale registration statement and any warrant exercises, share issuances, or sales.
- Reconcile the $8.83 million and $16.96 million proceeds with the company’s subsequent cash, debt, and liquidity disclosures.
- Assess the potential dilution from the 1,884,133-share penny warrant, 750,000-share additional warrant, amended February warrant, and other securities referenced in the filing.